Finance

Beta
Lists
301166:SHE
Shanghai Universal Biotech Co Ltd
CN¥27.06
-1.53%
(-0.42) 1D
Jun 4, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301166...
Open
CN¥27.60
High
CN¥27.61
Low
CN¥26.83
Mkt. cap
2.41B
Avg. vol.
1.26M
Volume
833.30K
Dividend
2.22%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 1, 2026
52-wk high
CN¥36.42
52-wk low
CN¥26.83
EPS
-CN¥0.29
Shares outstanding
86.17M
No. of employees
810
Open
CN¥27.60
High
CN¥27.61
Low
CN¥26.83
Mkt. cap
2.41B
Avg. vol.
1.26M
Volume
833.30K
Dividend
2.22%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 1, 2026
52-wk high
CN¥36.42
52-wk low
CN¥26.83
EPS
-CN¥0.29
Shares outstanding
86.17M
No. of employees
810
News stories
From sources across the web
About Shanghai Universal Biotech Co Ltd
CEO-
Employees810
FoundedOct 22, 2004
Headquarters-
SectorHealth care provider
Websiteuniv-bio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
288.46M
271.23M
307.64M
259.31M
Cost of goods sold
236.82M
217.69M
251.14M
206.64M
Cost of revenue
236.82M
217.69M
251.14M
206.64M
Research and development expenses
15.39M
17.63M
18.22M
18.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.31M
47.10M
52.84M
47.37M
Operating expense
63.13M
62.25M
80.43M
71.24M
Total operating expenses
299.95M
279.94M
331.57M
277.88M
Operating income
-11.49M
-8.71M
-23.93M
-18.57M
Other non operating income
101.22K
-1.50M
1.51M
329.35K
EBT including unusual items
-5.50M
-5.24M
-9.64M
-15.19M
EBT excluding unusual items
-9.42M
-5.30M
-21.08M
-16.37M
Income tax expense
1.67M
-3.54M
-1.78M
-6.70M
Effective tax rate
-30.29%
67.58%
18.41%
44.09%
Other operating expenses
977.86K
-4.98M
7.75M
1.12M
Net income
-7.17M
-1.70M
-7.87M
-8.50M
Net profit margin
-2.49%
-0.63%
-2.56%
-3.28%
Earnings per share
-
-
-
-
Interest and investment income
3.23M
3.64M
3.65M
1.87M
Interest expense
-
-
-904.42K
-
Net interest expenses
3.23M
3.64M
2.74M
1.87M
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.25M
-5.28M
-19.65M
-14.29M
Gain or loss from assets sale
643.25K
-643.25K
379.47K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer